General Information of the Compound
| Compound ID |
CP0561767
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
2-methyl-N-[(1S)-2-[(2S)-2-[5-[4-[4-[2-[(2S)-1-[(2R)-2-(2-methylpropanoylamino)-2-phenylacetyl]pyrrolidin-2-yl]-1,3-thiazol-5-yl]phenyl]phenyl]-1,3-thiazol-2-yl]pyrrolidin-1-yl]-2-oxo-1-phenylethyl]propanamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C50H52N6O4S2
|
||||||||||||||||||
| Molecular Weight |
865.138
|
||||||||||||||||||
| Canonical SMILES |
CC(C)C(=O)N[C@@H](C(=O)N1CCC[C@H]1c1ncc(s1)-c1ccc(cc1)-c1ccc(cc1)-c1cnc(s1)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)C(C)C)c1ccccc1)c1ccccc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C50H52N6O4S2/c1-31(2)45(57)53-43(37-13-7-5-8-14-37)49(59)55-27-11-17-39(55)47-51-29-41(61-47)35-23-19-33(20-24-35)34-21-25-36(26-22-34)42-30-52-48(62-42)40-18-12-28-56(40)50(60)44(54-46(58)32(3)4)38-15-9-6-10-16-38/h5-10,13-16,19-26,29-32,39-40,43-44H,11-12,17-18,27-28H2,1-4H3,(H,53,57)(H,54,58)/t39-,40-,43-,44+/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
HWRNBLKSZLPZJX-KOSLULIRSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound